TIFFINY PIZZIFRED: Open Payments
NPI 1407202328 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 96 payments from 15 companies in 2025. Trend: 2023 $2,500 · 2024 $2,167 · 2025 $2,068
Food & beverage: $1,873Education: $196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $320 |
| UCB, Inc. | 7 | $311 |
| Galderma Laboratories, L.P. | 16 | $310 |
| Arcutis Biotherapeutics, Inc. | 10 | $186 |
| Amgen Inc. | 14 | $170 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $147 |
| Regeneron Healthcare Solutions, Inc. | 4 | $136 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| LEO Pharma Inc. | 4 | $83 |
| PFIZER INC. | 4 | $75 |
Products named: Bimzelx, NEMLUVIO, Zoryve, SKYRIZI, Otezla, RINVOQ, DUPIXENT, COSENTYX.
Industry payments across CA — which companies pay providers there.
